Gilead Sciences
GILD
#81
Rank
S$265.01 B
Marketcap
S$213.66
Share price
-0.41%
Change (1 day)
38.97%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): -S$2.6 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are S$30.45 Billion. In 2025 the company made an earning of S$12.54 Billion, an increase over its 2024 earnings that were of S$0.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$2.6 Billion-120.66%
2025 S$12.54 B1319.86%
2024 S$0.88 B-89.94%
2023 S$8.78 B17.97%
2022 S$7.44 B-29.77%
2021 S$10.59 B395.99%
2020 S$2.13 B-67.66%
2019 S$6.60 B-33.84%
2018 S$9.98 B-42.35%
2017 S$17.32 B-20.87%
2016 S$21.88 B-21.06%
2015 S$27.72 B45.8%
2014 S$19.01 B253.01%
2013 S$5.38 B16.51%
2012 S$4.62 B-1.07%
2011 S$4.67 B-6.71%
2010 S$5.01 B11.75%
2009 S$4.48 B29.5%
2008 S$3.46 B19.11%
2007 S$2.90 B-455.74%
2006 -S$0.82 Billion-154.93%
2005 S$1.48 B76.99%
2004 S$0.84 B-266.16%
2003 -S$0.51 Billion-638.24%
2002 S$93.96 M31.5%
2001 S$71.46 M-242.15%
2000 -S$50.28 Million-40.2%
1999 -S$84.07 Million31.85%
1998 -S$63.76 Million8.73%
1997 -S$58.64 Million27.22%
1996 -S$46.09 Million
1994 -S$43.92 Million26.57%
1993 -S$34.7 Million46.49%
1992 -S$23.69 Million362.5%
1991 -S$5.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$23.96 B-1,057.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$8.84 B-453.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$11.13 B-544.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$44.51 B-1,878.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$13.17 B-626.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$1.29 B-151.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.48 B-159.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$6.45 B-358.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.84 B-493.35%๐Ÿ‡บ๐Ÿ‡ธ USA